InsidersTradesSigma
Explore the full record of transactions filed by HALE DAVID F, Director. Officer active across 3 companies, notably Dermata Therapeutics, Inc.. In total, 7 reports have been published. Total volume traded: €32k. The latest transaction was filed on 7 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
7 of 7 declarations
HALE DAVID F is a Director at Oncternal Therapeutics, Inc., Dermata Therapeutics, Inc., and BIOCEPT INC. In these roles, he participates in corporate governance and strategic decision-making. His expertise in the biopharmaceutical sector allows him to make significant contributions to board discussions, ensuring innovation and performance for the companies.